Matt Pelo

Matthew J. Pelo is one of the founding executives of the New York Genome Center (NYGC) where he spent nearly a decade building one of the largest clinical genomics institutions in the US. Matt held leadership positions in finance, operations and business development with notable highlights of establishing a $105M New York State Genomics initiative, adopting IBM Watson for cancer genomics and launching the first CLEP-approved constitutional whole genome in the US. Prior to NYGC, Matt was an investment banker focused on life science mergers, acquisitions, capital formation and strategic advisory.